Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Nuclear Medicine

Free Subscription Articles published in Nuklearmedizin Retrieve available abstracts of 123 articles: HTML format

Single Articles

July 2021
1. LAPA C, Nestle U, Albert NL, Baues C, et al
   Value of PET imaging for radiation therapy.
   Nuklearmedizin. 2021 Jul 14. doi: 10.1055/a-1525-7029.
   PubMed     Abstract available
   
   
   
2. KREPPEL B, Gonzalez-Carmona MA, Feldmann G, Kuppers J, et al
   Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours.
   Nuklearmedizin. 2021 Jul 13. doi: 10.1055/a-1521-8604.
   PubMed     Abstract available
   
   
   
3. SAHIN O, Kaya B, Aydin Z, Sen AE, et al
   Prostate incidentaloma on 18F-fluorodeoxyglucose positron emission tomography: Diagnostic value of volumetric positron emission tomography parameters.
   Nuklearmedizin. 2021 Jul 9. doi: 10.1055/a-1525-7607.
   PubMed     Abstract available
   
   
   June 2021
4. OBMANN VC, Grosse-Hokamp N, Alberts I, Fulton N, et al
   Diagnosis and staging of hepatobiliary malignancies: Potential incremental value of (18)F-FDG-PET/MRI compared to MRI of the liver.
   Nuklearmedizin. 2021 Jun 8. doi: 10.1055/a-1486-3671.
   PubMed     Abstract available
   
   
   
5. HELLWIG D
   Hope for new developments in the reimbursement of oncological PET/CT in Germany.
   Nuklearmedizin. 2021;60:205-208.
   PubMed    
   
   
   April 2021
6. BARENFANGER F, Block A, Schmelz D, Hamami-Arlinghaus M, et al
   Individual calculation of perfusion activity based on ventilation efficiency for V/P-SPECT.
   Nuklearmedizin. 2021 Apr 16. doi: 10.1055/a-1429-1832.
   PubMed     Abstract available
   
   
   
7. TATOGLU MT, Uslu H, Ibisoglu E
   The value of (18)F-FDG PET/CT in Diagnosis and Evaluation of Response to Treatment in Retroperitoneal Fibrosis.
   Nuklearmedizin. 2021 Apr 9. doi: 10.1055/a-1429-2237.
   PubMed    
   
   
   
8. FREUDENBERG LS, Essler M, Herrmann K
   [Impact of COVID-19 on Nuclear Medicine Procedures in Germany 2020 - Results of a National Survey].
   Nuklearmedizin. 2021 Apr 1. doi: 10.1055/a-1446-7641.
   PubMed     Abstract available
   
   
   March 2021
9. CHEN YH, Yu MM, Wang ZG
   Inhibition of MDA-MB-231 cell proliferation by pHLIP(Var7)-P1AP and SPECT imaging of MDA-MB-231 breast cancer-bearing nude mice using 125I-pHLIP(Var7)-P1AP.
   Nuklearmedizin. 2021 Mar 23. doi: 10.1055/a-1307-1923.
   PubMed     Abstract available
   
   
   February 2021
10. HAPPEL C, Borowski M, Kamp A, Rudolf F, et al
    [Prenatal Radiation Exposure in Nuclear Medicine].
    Nuklearmedizin. 2021 Feb 11. doi: 10.1055/a-1365-7954.
    PubMed     Abstract available
    
    
    
11. DADGAR H, Norouzbeigi N, Gholamrezanezhad A, Assadi M, et al
    Correction: Incidental Detections Suggestive of COVID-19 in Asymptomatic Patients Undergoing 68Ga-DOTATATE and 68Ga-PSMA-11 PET-CT Scan for Oncological Indications.
    Nuklearmedizin. 2021 Feb 9. doi: 10.1055/a-1379-4070.
    PubMed    
    
    
    
12. ZIPPEL C, Giesel FL, Kratochwil C, Eiber M, et al
    [PSMA radioligand therapy could pose infrastructural challenges for nuclear medicine: results of a basic calculation for the capacity planning of nuclear medicine beds in the German hospital sector].
    Nuklearmedizin. 2021 Feb 2. doi: 10.1055/a-1351-0030.
    PubMed     Abstract available
    
    
    
13. WIEDITZ M, Essler M, Luster M
    [Nursing in Nuclear medicine - decisive factor for future Theranostics].
    Nuklearmedizin. 2021;60:5-6.
    PubMed    
    
    
    January 2021
14. MINGELS C, Vollnberg B, Rominger A, Afshar-Oromieh A, et al
    Extended perfusion defects in lung perfusion-SPECT/CT in a case of fatal COVID-19 pneumonia.
    Nuklearmedizin. 2021 Jan 26. doi: 10.1055/a-1333-0226.
    PubMed    
    
    
    December 2020
15. DADGAR H, Norouzbeigi N, Gholamrezanezhad A, Assadi M, et al
    Incidental Detections Suggestive of COVID-19 in Asymptomatic Patients Undergoing 68Ga-DOTATATE and 68Ga-PSMA-11 PET-CT Scan for Oncological Indications.
    Nuklearmedizin. 2020 Dec 16. doi: 10.1055/a-1311-2856.
    PubMed    
    
    
    
16. LIU H, Liu Y, Chen Y, Liu H, et al
    68Ga-PSMA Uptake in Pulmonary Tuberculosis: A Pitfall in Prostate Cancer PET Imaging.
    Nuklearmedizin. 2020 Dec 10. doi: 10.1055/a-1312-6148.
    PubMed    
    
    
    
17. ESSLER M, Kreppel B
    [In Reply: Invisible Hand - Re: [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging].
    Nuklearmedizin. 2020;59:456.
    PubMed    
    
    
    
18. BIERSACK HJ, Ahmadzadehfar H
    Re: [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging.
    Nuklearmedizin. 2020;59:455.
    PubMed    
    
    
    
19. CARRIO I, Essler M, Freudenberg LS, Herrmann K, et al
    "COVID-19 Pandemic as stimulator to Re-Establish Nuclear Medicine as Clinical Specialty" based on a report of Prof. Dr. Ignasi Carrio.
    Nuklearmedizin. 2020;59:405-408.
    PubMed    
    
    
    November 2020
20. HARTMANN L, Bundschuh L, Zsoter N, Essler M, et al
    Tumor heterogeneity for differentiation between liver tumors and normal liver tissue in 18F-FDG PET/CT.
    Nuklearmedizin. 2020 Nov 3. doi: 10.1055/a-1270-5568.
    PubMed     Abstract available
    
    
    October 2020
21. BUDAK A, Beyan E, Inan AH, Kanmaz AG, et al
    PET Parameters are Useful in Predicting Endometrial Cancer Risk Classes and Prognosis.
    Nuklearmedizin. 2020 Oct 26. doi: 10.1055/a-1267-8976.
    PubMed     Abstract available
    
    
    
22. BIERMANN M, Kanoun S, Davidsen T, Gray R, et al
    An Open Source Solution for "Hands-on" teaching of PET/CT to Medical Students under the COVID-19 Pandemic.
    Nuklearmedizin. 2020 Oct 26. doi: 10.1055/a-1267-9017.
    PubMed     Abstract available
    
    
    
23. JUENGLING FD, Allenbach G, Bruehlmeier M, Klaeser B, et al
    Appropriate use criteria for dementia amyloid imaging in Switzerland - mini-review and statement on behalf of the Swiss Society of Nuclear Medicine and the Swiss Memory Clinics.
    Nuklearmedizin. 2020 Oct 20. doi: 10.1055/a-1277-6014.
    PubMed     Abstract available
    
    
    
24. BEGUM NJ, Glatting G, Eiber M, Beer AJ, et al
    An in silico study on the effect of the radionuclide half-life on PET/CT imaging with PSMA-targeting radioligands.
    Nuklearmedizin. 2020 Oct 16. doi: 10.1055/a-1253-1535.
    PubMed     Abstract available
    
    
    September 2020
25. KURTH J, Uhlander J, Aladwan H, Gohrendt A, et al
    Semi-automated Analysis of Ventilation-Perfusion Single-Photon Emission Tomography in the Diagnosis of Pulmonary Embolism - Does it add extra value?
    Nuklearmedizin. 2020 Sep 29. doi: 10.1055/a-1253-7951.
    PubMed     Abstract available
    
    
    
26. MOKOALA KMG, Lawal IO, Lengana T, Popoola GO, et al
    18F-FDG PET/CT imaging of vulva cancer recurrence: A comparison of PET-derived metabolic parameters between women with and without HIV infection.
    Nuklearmedizin. 2020 Sep 1. doi: 10.1055/a-1221-7810.
    PubMed     Abstract available
    
    
    July 2020
27. DORAU-RUTKE V, Huang K, Lukas M, Schulze MO, et al
    18F-sodium fluoride bone deposition quantitation with PET in Mice: Variation with age, sex, and circadian rhythm.
    Nuklearmedizin. 2020 Jul 16. doi: 10.1055/a-1205-0082.
    PubMed     Abstract available
    
    
    June 2020
28. SCHLEUPNER MC, Riemann B, Schafers M, Backhaus P, et al
    Impact of FDG-PET on therapy management and outcome of differentiated thyroid carcinoma patients with elevated thyroglobulin despite negative iodine scintigraphy.
    Nuklearmedizin. 2020 Jun 15. doi: 10.1055/a-1177-9728.
    PubMed     Abstract available
    
    
    May 2020
29. KREPPEL B, Gartner FC, Marinova M, Attenberger U, et al
    [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging.
    Nuklearmedizin. 2020 May 11. doi: 10.1055/a-1164-5667.
    PubMed    
    
    
    April 2020
30. FREUDENBERG LS, Dittmer U, Herrmann K
    Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland: An International Survey in April 2020.
    Nuklearmedizin. 2020 Apr 28. doi: 10.1055/a-1163-3096.
    PubMed     Abstract available
    
    
    
31. LUTJE S, Marinova M, Kutting D, Attenberger U, et al
    Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19.
    Nuklearmedizin. 2020 Apr 7. doi: 10.1055/a-1152-2341.
    PubMed     Abstract available
    
    
    
32. DITTRICH D, Pyka T, Scheidhauer K, Lutje S, et al
    Textural features in FGD-PET/CT can predict outcome in melanoma patients to treatment with Vemurafenib and Ipililumab.
    Nuklearmedizin. 2020 Apr 7. doi: 10.1055/a-1140-5458.
    PubMed     Abstract available
    
    
    
33. HEINZEL A, Marienhagen J, Yekta-Michael SS, Mottaghy FM, et al
    Pilot study of a newly developed eLearning tool to teach CT and PET/CT in radiology and nuclear medicine.
    Nuklearmedizin. 2020;59:79-84.
    PubMed     Abstract available
    
    
    
34. KRAUSE BJ, Bartenstein P, Freudenberg LS, Herrmann K, et al
    
    Nuklearmedizin. 2020;59:e1-e4.
    PubMed    
    
    
    March 2020
35. MENERET P, Girard A, Pagenault M, Riffaud L, et al
    Different manifestations detected with 68Ga-DOTATOC PET/CT in patients with Von Hippel-Lindau disease: A case report.
    Nuklearmedizin. 2020 Mar 19. doi: 10.1055/a-1132-5104.
    PubMed    
    
    
    
36. FECH V, Sachpekidis C, Alberts I, Rominger A, et al
    Atypical metastatic pattern of prostate cancer detected with 68Ga-PSMA PET/CT.
    Nuklearmedizin. 2020 Mar 18. doi: 10.1055/a-1108-1275.
    PubMed    
    
    
    
37. KOTZERKE J, Fetzer P, Grosche-Schlee S, Hanel A, et al
    [Development of a system for risk analysis in treatment with unsealed radioactive substances in nuclear medicine].
    Nuklearmedizin. 2020 Mar 3. doi: 10.1055/a-1119-0849.
    PubMed     Abstract available
    
    
    February 2020
38. CEGLA P, Burchardt E, Cholewinski W, Gwozdz S, et al
    Comparison of semiquantitative metabolic parameters of the primary tumor obtained in PET/CT with 18F-FDG and 18F-FLT in patients with cervical cancer.
    Nuklearmedizin. 2020 Feb 25. doi: 10.1055/a-1084-4766.
    PubMed     Abstract available
    
    
    
39. BUDAK E, Yanarates A
    PET/CT Parameters are Useful in Discrimination of Incidental Benign, Premalignant and Malignant Colonic Lesions.
    Nuklearmedizin. 2020 Feb 24. doi: 10.1055/a-1084-4723.
    PubMed     Abstract available
    
    
    
40. DIETLEIN M, Klussmann JP, Drzezga A
    [18F-FDG PET/CT in head and neck tumors].
    Nuklearmedizin. 2020;59:8-11.
    PubMed    
    
    
    
41. LUSTER M
    [Back to the Future - Chances and Challenges for Nuclear Medicine].
    Nuklearmedizin. 2020;59:6-7.
    PubMed    
    
    
    January 2020
42. BIALEK EJ, Malkowski B
    Is the level of diffusion restriction in celiac and cervico-thoracic sympathetic ganglia helpful in their proper recognition on PSMA ligand PET/MR?
    Nuklearmedizin. 2020 Jan 31. doi: 10.1055/a-1079-3855.
    PubMed     Abstract available
    
    
    December 2019
43. KUHNEL C, Seifert P, Mulik C, Winkens T, et al
    3D printing of fillable individual thyroid replicas based on nuclear medicine DICOM data used as phantoms for gamma probe calibration.
    Nuklearmedizin. 2019 Dec 19. doi: 10.1055/a-1070-9874.
    PubMed     Abstract available
    
    
    
44. BURCHERT W, Hugenberg V
    [The Gordian Knot 2.0 - Decentralized production of radiopharmaceuticals].
    Nuklearmedizin. 2019;58:420-423.
    PubMed    
    
    
    November 2019
45. ALBERTS I, Sachpekidis C, Fech V, Rominger A, et al
    PSMA-negative prostate cancer and the continued value of choline-PET/CT.
    Nuklearmedizin. 2019 Nov 25. doi: 10.1055/a-1044-1855.
    PubMed    
    
    
    
46. WUNDERLICH G, Freudenberg R, Hartmann H, Herrling P, et al
    [Radiation Exposition of preparations of radiopharmaceuticals in routinely use, measured with optical-stimulated luminescence (OSL) dosimeters].
    Nuklearmedizin. 2019 Nov 13. doi: 10.1055/a-1031-9251.
    PubMed     Abstract available
    
    
    
47. MICHALSKI K, Mix M, Meyer PT, Ruf J, et al
    Determination of whole-body tumour burden on [68Ga]PSMA-11 PET/CT for response assessment of [177Lu]PSMA-617 radioligand therapy: a retrospective analysis of serum PSA level and imaging derived parameters before and after two cycles of therapy.
    Nuklearmedizin. 2019 Nov 13. doi: 10.1055/a-1035-9052.
    PubMed     Abstract available
    
    
    
48. WINKENS T, Seifert P, Hollenbach C, Kuhnel C, et al
    The FUSION iENA Study: Comparison of I-124-PET/US Fusion Imaging with Conventional Diagnostics for the Functional Assessment of Thyroid Nodules by Multiple Observers.
    Nuklearmedizin. 2019 Nov 11. doi: 10.1055/a-1031-9832.
    PubMed     Abstract available
    
    
    
49. WEISSINGER M, Kupferschlager J, La Fougere C, Dittmann H, et al
    Transitioning to whole-body SPECT/CT in prostate cancer staging: a new concept for a better imaging workflow.
    Nuklearmedizin. 2019 Nov 11. doi: 10.1055/a-1022-4115.
    PubMed     Abstract available
    
    
    October 2019
50. LINDNER O, Burchert W, Buechel R, Schafer WM, et al
    Myocardial Perfusion SPECT 2018 in Germany: Results of the 8th Survey.
    Nuklearmedizin. 2019 Oct 24. doi: 10.1055/a-1023-3960.
    PubMed     Abstract available
    
    
    
51. HEINZEL A, Mottaghy FM, Brenner W, Marienhagen J, et al
    [The teaching of nuclear medicine in Germany].
    Nuklearmedizin. 2019 Oct 10. doi: 10.1055/a-1011-3481.
    PubMed     Abstract available
    
    
    September 2019
52. ANKRAH AO, Lawal IO, Boshomane TMG, Klein HC, et al
    Comparison of Fluorine(18)-fluorodeoxyglucose and Gallium(68)-citrate PET/CT in patients with tuberculosis.
    Nuklearmedizin. 2019 Sep 4. doi: 10.1055/a-1000-6951.
    PubMed     Abstract available
    
    
    August 2019
53. LEONHAUSER B, Happel C, Groner D, Bockisch B, et al
    [Evaluation of intratherapeutic 177Lu-HA-DOTATATE treatment in neuroendocrine tumors: dosimetry with SPECT, whole-body imaging and gamma probe].
    Nuklearmedizin. 2019 Aug 28. doi: 10.1055/a-0987-9689.
    PubMed     Abstract available
    
    
    
54. HOBERUCK S, Michler E, Wunderlich G, Lock S, et al
    68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patients.
    Nuklearmedizin. 2019 Aug 23. doi: 10.1055/a-0990-8898.
    PubMed     Abstract available
    
    
    
55. GUHNE F, Drescher R, Seifert P, Freesmeyer M, et al
    Minimal-activity PET/CT for efficacy control after SIRT (MAPECSI) - clinical implementation of a resource-saving, liver-focused protocol.
    Nuklearmedizin. 2019 Aug 14. doi: 10.1055/a-0985-3954.
    PubMed     Abstract available
    
    
    July 2019
56. MICHLER E, Hoberuck S, Martino F, Platzek I, et al
    Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI.
    Nuklearmedizin. 2019 Jul 25. doi: 10.1055/a-0972-0698.
    PubMed     Abstract available
    
    
    June 2019
57. SABET A, Ries M, Al-Khalaf Y, Meyer C, et al
    Early metabolic response assessment of breast cancer liver metastases: 4-week posttreatment FDG PET predicts survival after 90Y microsphere radioembolization.
    Nuklearmedizin. 2019;58:242-248.
    PubMed     Abstract available
    
    
    
58. KIRCHER M, Seifert S, Kircher S, Lapa C, et al
    [99mTc]Tilmanocept Lymphscintigraphy after inconclusive [99mTc]Nanocolloid Scan in Breast Cancer.
    Nuklearmedizin. 2019;58:282-284.
    PubMed     Abstract available
    
    
    
59. VERBURG FA, Schmidt M, Kreissl MC, Grunwald F, et al
    [Procedural guideline for Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma (version 5)].
    Nuklearmedizin. 2019;58:228-241.
    PubMed     Abstract available
    
    
    
60. SCHNEIDER C, Dietlein M, Faust M, Drzezga A, et al
    Thyroid hemiagenesis is combined with a variety of thyroid disorders.
    Nuklearmedizin. 2019;58:265-271.
    PubMed     Abstract available
    
    
    
61. MICHALSKI K, Kurz P, Fuellgraf H, Pfeiffer J, et al
    TTF-1 positive atypical carcinoid of the epiglottis mimicking medullary thyroid carcinoma.
    Nuklearmedizin. 2019;58:279-281.
    PubMed    
    
    
    May 2019
62. FECH V, Alberts I, Rominger A, Afshar-Oromieh A, et al
    PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomography.
    Nuklearmedizin. 2019 May 13. doi: 10.1055/a-0895-5078.
    PubMed     Abstract available
    
    
    
63. SCHENKE S, Klett R, Acker P, Rink T, et al
    Interobserver Agreement of Planar and SPECT Tc99m-MIBI Scintigraphy for the Assessment of Hypofunctioning Thyroid Nodules.
    Nuklearmedizin. 2019 May 10. doi: 10.1055/a-0894-4843.
    PubMed     Abstract available
    
    
    April 2019
64. YI C, Shi X, Yu D, Luo G, et al
    The combination of 13N-ammonia and 18F-FDG PET/CT in the identification of metabolic phenotype of primary human brain tumors.
    Nuklearmedizin. 2019 Apr 17. doi: 10.1055/a-0835-5746.
    PubMed     Abstract available
    
    
    March 2019
65. KOHLER A, Lock S, Appold S, Bandurska-Luque A, et al
    Comparison of subjective evaluation versus objective algorithm in the interpretation of follow-up FDG-PET/CT scans after radiochemotherapy in head and neck cancer patients.
    Nuklearmedizin. 2019;58:93-100.
    PubMed     Abstract available
    
    
    
66. ZIPPEL C, Neels OC, Hennrich U, Giesel FL, et al
    [Initiation of clinical multicentre studies with local radiotracer production - Regulatory environment and radiopharmaceutical-organisational aspects].
    Nuklearmedizin. 2019;58:77-85.
    PubMed     Abstract available
    
    
    February 2019
67. UMUTLU L, Beyer T, Grueneisen JS, Rischpler C, et al
    Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation.
    Nuklearmedizin. 2019 Feb 28. doi: 10.1055/a-0830-4453.
    PubMed     Abstract available
    
    
    
68. HUANG EL, Steffen IG, Lukas M, Huang K, et al
    Normal Values for Parotid Gland and Submandibular-Sublingual Salivary Gland Complex Uptake of 99mTechnetium Pertechnetate using SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm.
    Nuklearmedizin. 2019;58:39-49.
    PubMed     Abstract available
    
    
    
69. CERNY M, Dunet V, Rebecchini C, Hahnloser D, et al
    Response of locally advanced rectal cancer (LARC) to radiochemotherapy: DW-MRI and multiparametric PET/CT in correlation with histopathology.
    Nuklearmedizin. 2019;58:28-38.
    PubMed     Abstract available
    
    
    
70. VERBURG FA, Wiessmann M, Neuloh G, Mottaghy FM, et al
    Intraindividual comparison of selective intraarterial versus systemic intravenous 68Ga-DOTATATE PET/CT in patients with inoperable meningioma.
    Nuklearmedizin. 2019;58:23-27.
    PubMed     Abstract available
    
    
    
71. CEGLA P, Urbanski B, Burchardt E, Roszak A, et al
    Influence of 18F-FDG-PET/CT on staging of cervical cancer.
    Nuklearmedizin. 2019;58:17-22.
    PubMed     Abstract available
    
    
    
72. TATSCH K, Buchert R, Bartenstein P, Barthel H, et al
    [Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)].
    Nuklearmedizin. 2019;58:5-16.
    PubMed     Abstract available
    
    
    December 2018
73. FREESMEYER M, Weigand W, Weisheit T
    Examination of the complexation ability of different calixarene derivatives towards [223Ra]RaCl2 in a hospital radiopharmaceutical laboratory.
    Nuklearmedizin. 2018;57:242-246.
    PubMed     Abstract available
    
    
    
74. LEI J, Yu P, Xu B, Wang R, et al
    Worldwide research productivity in nuclear medicine literature.
    Nuklearmedizin. 2018;57:234-241.
    PubMed     Abstract available
    
    
    
75. HUANG K, Lukas M, Steffen IG, Lange C, et al
    Normal Values of Renal Function measured with 99mTechnetium Mercaptoacetyltriglycine SPECT in Mice with Respect to Age, Sex and Circadian Rhythm.
    Nuklearmedizin. 2018;57:224-233.
    PubMed     Abstract available
    
    
    
76. QIAN X, Wenqi Z, Shi G, Bin C, et al
    Indeterminate solitary vertebral lesions on planar scintigraphy.
    Nuklearmedizin. 2018;57:216-223.
    PubMed     Abstract available
    
    
    
77. LEI J, Yu P, Xu B, Wang R, et al
    Correction: Worldwide research productivity in nuclear medicine literature.
    Nuklearmedizin. 2018;57:E1.
    PubMed    
    
    
    
78. GRUNWALD L, Derwahl KM, Steinmuller T, Kuwert T, et al
    
    Nuklearmedizin. 2018;57:N55-N56.
    PubMed    
    
    
    
79. 
    
    Nuklearmedizin. 2018;57:XIV.
    PubMed    
    
    
    
80. SAILER R, Wienke A
    
    Nuklearmedizin. 2018;57:IX-X.
    PubMed    
    
    
    
81. WIENKE A, Friese K
    
    Nuklearmedizin. 2018;57:VI-VIII.
    PubMed    
    
    
    September 2018
82. BOUTER Y, Meller B, Sahlmann CO, Wolf BJ, et al
    Immunohistochemical detection of chemokine receptor 4 expression in chronic osteomyelitis confirms specific uptake in 68Ga-Pentixafor-PET/CT.
    Nuklearmedizin. 2018;57:198-203.
    PubMed     Abstract available
    
    
    
83. LAWAL IO, Ankrah AO, Mokoala KMG, Popoola GO, et al
    Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection.
    Nuklearmedizin. 2018;57:190-197.
    PubMed     Abstract available
    
    
    
84. BEINDORFF N, Bartelheimer A, Huang K, Lukas M, et al
    Normal Values of Thyroid Uptake of 99mTechnetium Pertechnetate SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm.
    Nuklearmedizin. 2018;57:181-189.
    PubMed     Abstract available
    
    
    
85. LIMA GM, Bonfiglioli R, Matti A, Fanti S, et al
    Fluoride PET/CT in Metastatic Benign Pulmonary Calcification.
    Nuklearmedizin. 2018;57:N50-N51.
    PubMed    
    
    
    
86. 
    
    Nuklearmedizin. 2018;57:N53.
    PubMed    
    
    
    August 2018
87. GROSSER OS, Ruf J, Kupitz D, Czuczwara D, et al
    Image Quality Assessment for Low-Dose-CT in Hybrid SPECT/CT Imaging.
    Nuklearmedizin. 2018;57:153-159.
    PubMed     Abstract available
    
    
    
88. VERBURG FA, Grunwald F, Lassmann M, Hanscheid H, et al
    [Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma].
    Nuklearmedizin. 2018;57:124-136.
    PubMed     Abstract available
    
    
    
89. LINDNER O, Bauersachs J, Bengel FM, Burchert W, et al
    [Policy paper nuclear cardiology - update 2018 - Current status of clinical practice].
    Nuklearmedizin. 2018;57:146-152.
    PubMed     Abstract available
    
    
    
90. 
    
    Nuklearmedizin. 2018;57:N33-N49.
    PubMed    
    
    
    June 2018
91. CHOI BW, Won Kim H, Jeon JC, Kang S, et al
    Nodular fasciitis mimicking malignant soft tissue tumor in an infant, with 18F-FDG PET/CT findings: A case report.
    Nuklearmedizin. 2018;57:N29-N31.
    PubMed    
    
    
    
92. STANZEL S, Pernthaler B, Schwarz T, Bjelic-Radisic V, et al
    Diagnostic and prognostic value of additional SPECT/CT in sentinel lymph node mapping in breast cancer patients.
    Nuklearmedizin. 2018;57:92-99.
    PubMed     Abstract available
    
    
    
93. KOTZERKE J, Bohmer D, Schlomm T, Maurer T, et al
    [PSMA-PET/CT has to be performed in every patient with biochemical recurrence following radical prostatectomy for early tumor detection].
    Nuklearmedizin. 2018;57:69-73.
    PubMed     Abstract available
    
    
    
94. BRAUNE A, Scharffenberg M, Naumann A, Bluth T, et al
    Comparison of 68Ga- and fluorescence-labeled microspheres for measurement of relative pulmonary perfusion in anesthetized pigs.
    Nuklearmedizin. 2018;57:100-107.
    PubMed     Abstract available
    
    
    
95. SCHUMICHEN C, Schmidt M, Krause T
    [Lung scintigraphy].
    Nuklearmedizin. 2018;57:74-91.
    PubMed     Abstract available
    
    
    
96. 
    
    Nuklearmedizin. 2018;57:N32.
    PubMed    
    
    
    
97. KRAUSE BJ
    
    Nuklearmedizin. 2018;57:66-67.
    PubMed    
    
    
    April 2018
98. SCHOEN M, Braun T, Manava P, Ludwigs S, et al
    Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
    Nuklearmedizin. 2018;57:50-55.
    PubMed     Abstract available
    
    
    
99. 
    
    Nuklearmedizin. 2018;57:N14-N27.
    PubMed    
    
    
    
100. BRENNER W
     
     Nuklearmedizin. 2018;57:N9.
     PubMed    
     
     
     February 2018
101. SCHAEFER WM, Knollmann D, Avondo J, Meyer A, et al
     Volume/perfusion ratio from lung SPECT/CT.
     Nuklearmedizin. 2018;57:31-34.
     PubMed     Abstract available
     
     
     
102. DRAGER DL, Heuschkel M, Protzel C, Erbersdobler A, et al
     [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
     Nuklearmedizin. 2018;57:26-30.
     PubMed     Abstract available
     
     
     
103. BOY C, Poeppel T, Kotzerke J, Krause BJ, et al
     [Somatostatin receptor PET/CT (SSTR-PET/CT)].
     Nuklearmedizin. 2018;57:4-17.
     PubMed     Abstract available
     
     
     
104. ROGASCH JMM, Amthauer H, Furth C, Hundsdoerfer P, et al
     I-123-MIBG scintigraphy in patients with neuroblastoma.
     Nuklearmedizin. 2018;57:35-39.
     PubMed     Abstract available
     
     
     
105. FILSS C, Heinzel A, Miiller B, Vogg ATJ, et al
     Relevant tumor sink effect in prostate cancer patients receiving 177Lu-PSMA-617 radioligand therapy.
     Nuklearmedizin. 2018;57:19-25.
     PubMed     Abstract available
     
     
     
106. COENEN HH, Gee AD, Adam M, Antoni G, et al
     International Consensus Radiochemistry Nomenclature Guidelines.
     Nuklearmedizin. 2018;57:40-41.
     PubMed    
     
     
     
107. 
     
     Nuklearmedizin. 2018;57:18.
     PubMed    
     
     
     
108. BURCHERT W
     
     Nuklearmedizin. 2018;57:N6-N8.
     PubMed    
     
     
     
109. PICHLER B
     
     Nuklearmedizin. 2018;57:N5.
     PubMed    
     
     
     
110. 
     
     Nuklearmedizin. 2018;57:N5.
     PubMed    
     
     
     
111. 
     
     Nuklearmedizin. 2018;57:N4.
     PubMed    
     
     
     
112. RISCHPLER C, Schwamborn K, Schwaiger M, Maurer T, et al
     Radio-guided-surgery of a paravertebral paraganglioma using I-123-MIBG.
     Nuklearmedizin. 2018;57:N2-N3.
     PubMed    
     
     
     July 2017
113. ZHANG Y, Li B, Shi H, Yu H, et al
     Added value of SPECT/spiral CT versus SPECT or CT alone in diagnosing solitary skeletal lesions.
     Nuklearmedizin. 2017;56.
     PubMed     Abstract available
     
     
     June 2017
114. LINDNER O, Bengel F, Burchert W, Dorr R, et al
     [Myokard-Perfusions-SPECT. Myocardial perfusion SPECT - Update S1 guideline].
     Nuklearmedizin. 2017;56.
     PubMed     Abstract available
     
     
     May 2017
115. LEE JW, Park JS, Park KB, Yoo GH, et al
     Prediction of renal cortical defect and scar using neutrophil-to-lymphocyte ratio in children with febrile urinary tract infection.
     Nuklearmedizin. 2017 May 10. doi: 10.3413/Nukmed-0878.
     PubMed     Abstract available
     
     
     April 2017
116. LUTJE S, Cohnen J, Gomez B, Gruneisen J, et al
     Integrated 68Ga-HBED-CC-PSMA-PET/MRI in patients with suspected recurrent prostate cancer.
     Nuklearmedizin. 2017 Apr 12. doi: 10.3413/Nukmed-0850.
     PubMed     Abstract available
     
     
     December 2016
117. ILHAN H, Mustafa M, Bartenstein P, Kuwert T, et al
     Rate of elimination of radioiodine-avid lymph node metastases of differentiated thyroid carcinoma by postsurgical radioiodine ablation. A bicentric study.
     Nuklearmedizin. 2016;55:221-227.
     PubMed     Abstract available
     
     
     September 2016
118. POPPEL TD, Andreeff M, Becherer A, Bockisch A, et al
     [Therapy of bone metastases with radium-223. German guidelines].
     Nuklearmedizin. 2016;55:177-86.
     PubMed     Abstract available
     
     
     August 2016
119. LI B, Zhang M, Jin J
     Unusual FDG uptakes of mesenteric brown adipose tissue in a patient with pheochromocytomas.
     Nuklearmedizin. 2016;55:N32-3.
     PubMed    
     
     
     
120. SCHUTZE C, Knoop BO, Vehrenkamp I, Rudolf F, et al
     [Constancy check of system linearity for dose calibrators. Effect of molybdenum impurities at high start activities of 99mTc].
     Nuklearmedizin. 2016;55:172-5.
     PubMed     Abstract available
     
     
     
121. KIM SJ, Choi JY, Lee JH, Hyun SH, et al
     Incidental 99mTc MDP uptake in the intestines and intravenous CT contrast.
     Nuklearmedizin. 2016;55:166-71.
     PubMed     Abstract available
     
     
     June 2016
122. FENDLER WP, Kratochwil C, Ahmadzadehfar H, Rahbar K, et al
     [177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer].
     Nuklearmedizin. 2016;55:123-8.
     PubMed     Abstract available
     
     
     
123. DIETLEIN M, Eschner W, Grunwald F, Lassmann M, et al
     [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].
     Nuklearmedizin. 2016;55:77-89.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: